CoChat
Sign Up
Cited by 403Pregnancy and Medication ImpactMaternal Mental Health During Pregnancy and PostpartumPrenatal Substance Exposure Effects

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Use of antidepressant medications during pregnancy: a multisite study

Andrade, Susan E., Raebel, Marsha A., Brown, Jeffrey, Lane, Kimberly, Livingston, James, Boudreau, Denise, Rolnick, Sharon J., Roblin, Douglas, Smith, David H., Willy, Mary E., Staffa, Judy A., Platt, Richard·2008·American Journal of Obstetrics and Gynecology
DOI 10.1016/j.ajog.2007.07.036
Open this paper in CoChat — free account

Abstract

Objective This study was undertaken to provide information on the prevalence of use of antidepressant drugs among pregnant women in the United States.Study design A retrospective study was conducted using the automated databases of 7 health plans. Women who delivered an infant in a hospital were identified. Antidepressant drug use was evaluated assuming a gestational duration of 270 days.Results Among the 118,935 deliveries occurring from 2001-2005, 6.6% of women were dispensed an antidepressant during pregnancy. Antidepressant drug use increased from 2.0% in 1996 to 7.6% of deliveries in 2004 and 2005. Selective serotonin reuptake inhibitor use increased from 1.5% in 1996 to 6.4% in 2004 and 6.2% in 2005.Conclusion Our finding that nearly 8% of pregnant women were prescribed antidepressants drugs during the years 2004 and 2005 highlights the importance of understanding the effects of these medications on the developing fetus and on the pregnant woman.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ajog.2007.07.036

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 18 references

Research works printed but not linked: 2

  1. 2006, Paxil and the risk of birth defects, FDA Consumer, 40, 4
  2. Alwan, 2005, Maternal use of selective serotonin re-uptake inhibitors and risk for birth defects, Birth Defects Res A Clin Mol Teratol, 73, 291

Cited by

Sorted by citations

Items 301–400 of 402

Related

See all

Metadata

Authors
Andrade, S. E., Raebel, M. A., Brown, J., Lane, K., Livingston, J., Boudreau, D., Rolnick, S. J., Roblin, D., Smith, D. H., Willy, M. E., Staffa, J. A., & Platt, R.
Affiliations
  • University of Massachusetts Chan Medical School (US)
  • Kaiser Permanente (US)
  • Harvard University (US)
  • Group Health Cooperative (US)
  • HealthPartners (US)
  • United States Food and Drug Administration (US)
Corresponding author
Andrade, Susan E.
ORCID
Venue
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Published
2008-02
Volume
198
Issue
2
Pages
194.e1-194.e5
ISSN
0002-9378 (ISSN-L)
DOI
10.1016/j.ajog.2007.07.036
OpenAlex
W2063638540
Cited by
403
References
18
Citations by year
2026: 1 · 2025: 10 · 2024: 9 · 2023: 8 · 2022: 17 · 2021: 9 · 2020: 24 · 2019: 24 · 2018: 24 · 2017: 27 · 2016: 38 · 2015: 37 · 2014: 28 · 2013: 43 · 2012: 39
FWCI
15.45
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • American Journal of Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
antidepressant use in pregnancy, selective serotonin reuptake inhibitors, maternal mental health, prenatal drug exposure, health insurance claims
MeSH terms
Adolescent, Adult, Antidepressive Agents, Depressive Disorder, Female, Health Maintenance Organizations, Humans, Infant, Newborn, Middle Aged, Practice Patterns, Physicians', Pregnancy, Pregnancy Complications, Prenatal Care, Retrospective Studies, United States, Databases, Factual, Selective Serotonin Reuptake Inhibitors, Drug Utilization Review

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review